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a  b  s  t  r  a  c  t
Paracoccidioidomycosis is a systemic and endemic mycosis, restricted to tropical and sub-
tropical areas of Latin America. The infection is caused by the thermal dimorphic fungus
Paracoccidioides brasiliensis and Paracoccidioides lutzii. The diagnosis of paracoccidioidomyco-
sis  is usually performed by microscopic examination, culture and immunodiagnostic tests
to  respiratory specimens, body ﬂuids and/or biopsies; however these methods require labo-
ratory personnel with experience and several days to produce a result. In the present study,
we  have validated and evaluated a nested PCR assay targeting the gene encoding the Para-
coccidioides gp43 membrane protein in 191 clinical samples: 115 samples from patients with
proven infections other than paracoccidioidomycosis, 51 samples as negative controls, and
25  samples from patients diagnosed with paracoccidioidomycosis. Additionally, the speci-
ﬁcity  of the nested PCR assay was also evaluated using puriﬁed DNA isolated from cultures
of  different microorganisms (n = 35) previously identiﬁed by culture and/or sequencing. The
results showed that in our hands, this nested PCR assay for gp43 protein showed speciﬁcityand sensitivity rates of 100%. The optimized nested PCR conditions in our laboratory allowed
detection down to 1 fg of P. brasiliensis DNA.
© 2015 Elsevier Editora Ltda. All rights reserved.∗ Corresponding author at: Carrera 72a, No. 78b-141, Medellin, Colombia
E-mail address: tnaranjo@cib.org.co (T.W. Naranjo).
http://dx.doi.org/10.1016/j.bjid.2015.04.008
1413-8670/© 2015 Elsevier Editora Ltda. All rights reserved..
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ntroduction
aracoccidioidomycosis (PCM) is an important systemic gran-
lomatous disease restricted to tropical and subtropical
ndemic areas in Latin America, from Mexico to northern
rgentina caused by the thermal dimorphic fungi of Paracoc-
idioides genus.1
Until 2006, it was considered that this genus consisted of
 single species, Paracoccidioides brasiliensis, however, molecu-
ar studies have revealed four distinct phylogenetic species: S1
present in Brazil, Argentina, Paraguay, Peru and Venezuela),
S2 (found in Brazil and Venezuela), PS3 (restricted exclusively
o Colombia), and PS4 (recently identiﬁed clinical isolates in
enezuela).2–5 However, a new monophyletic species, Paracoc-
idioides lutzii formerly known as ‘Pb01-like’ strains in the P.
rasiliensis complex, has been proposed as a new species based
n phylogenetic and comparative genomics data, recombi-
ation analysis, and morphological characteristics.6 There is
ittle information about the prevalence or incidence of this
ew species; the few cases of PCM caused by P. Lutzii have been
eported predominately in the central west region of Brazil,
rincipally at Mato Grosso and Goias states.7–9 However, there
s evidence of some reported cases outside this area10 and
utside Brazil.11 In respect to Colombia, there have been no
eported cases of PCM caused by P. lutzii; so far, all cases of PCM
eported in Colombia were caused by P. brasiliensis, although
hese cases were diagnosed by conventional laboratory tests.
Both species grow in the mycelial form at room tempera-
ure or in the budding yeast form in host tissue or in culture
t 36 ◦C. It is well accepted that the infection is acquired
hrough inhalation of infectious particles (conidia) produced
y the fungus mycelia form present in its as yet unknown
atural habitat.12–14 In this infectious disease, the fungus can
emain restricted to the lungs, the primary focus of infection,
r spread to other organs and tissues, resulting in diverse clin-
cal manifestations.
Different clinical forms of the disease are recognized and
he severity depends on the gender, age, and immune status
f the host, as well as on the size of the inhaled fungal inocu-
um. The infection could be asymptomatic or may give rise
o different forms of disease as follows: regressive sub-clinical
nfection, progressive disease that may be either chronic (adult
ype) or acute/sub-acute (juvenile type), and the residual
orm.13
PCM shows a broad geographic distribution of cases from
exico to Argentina; Brazil has the highest incidence but in
enezuela, Colombia, Ecuador, and Argentina many cases of
CM have also been reported.14–16 In Brazil areas where PCM
s highly endemic, the estimated incidence ranges from 10
o 30 cases/million inhabitants and a mortality rate of 1.4
eaths/million inhabitants.17
The diagnosis of PCM is usually made by microscopic detec-
ion of rounded yeast with peripheral budding giving a “ship’s
heel” appearance, which are observed directly on patient’s
linical samples, especially in sputum and in skin or mucous
embrane biopsies.13,14,18 Depending on the histopatholog-cal pattern it is possible that small forms of Paracoccidioides
ay be mistaken with other fungi.14,18–20 The gold standard
o diagnosis of PCM is still the microbiological culture with a5;1 9(4):376–383 377
disadvantage that the fungus growing can take up to six weeks
to yield some result.20–22 In this sense, diagnostic immuno-
diagnostic techniques based on detection of antibodies or
fungal antigens are of special value.15,18,20,23 Nevertheless,
these techniques yield many  cases of cross-reactivity with
other fungi and false-negative results in patients with some
type of immunodeﬁciency.8,18,20,24
In the last decade, several molecular methods such as poly-
merase chain reaction (PCR) have been developed for DNA
detection of P. brasiliensis in clinical samples, providing both
high sensitivity and speciﬁcity rates.25–28 The most frequently
used target sequences for molecular detection of P. brasilien-
sis have been the gp4323 and ribosomal DNA genes.26,29 These
PCR assays have been used to detect P. brasiliensis in the sera
and tissues of infected mice,23,26,27 in artiﬁcially contaminated
soil and in environmental samples.26,30 However, molecular
diagnosis of PCM is not currently used in clinical routine.
In the present study, our aim was to assess PCM the diag-
nostic accuracy of a nested PCR technique targeting the gene
coding for the speciﬁc gp43 protein of P. brasiliensis using bio-
logical samples from in a cohort of patients with suspected
or clinically diagnosed PCM. In addition, to implement this
molecular assay as an integral component of the diagnostic
tests regularly used in our laboratory for the diagnosis of PCM
in patients suspected of fungal infection.
Materials  and  methods
Over the 17-month period, from January 2011 to June 2012,
25 clinical samples from 25 patients with conﬁrmed PCM
were collected. The clinical specimens included: bronchoal-
veolar lavage (BAL, n = 2), biopsies (n = 15), and sputum (n = 8).
All of the specimens were collected at hospitals in Medellín,
Colombia, and sent to the Medical and Experimental Mycology
Unit of the Corporación para Investigaciones Biológicas (CIB),
for mycological diagnosis. Of the 25 samples positives for P.
brasiliensis, 15 (60%) were diagnosed by culture and 10 (40%)
by microscopic direct examination using KOH; all then where
subsequently analyzed by a gp43 nested PCR.
To assess the speciﬁcity of the nested PCR, we  ana-
lyzed 115 clinical samples from patients suffering from the
following infections conﬁrmed by culture or direct examina-
tion: aspergillosis (n = 19), candidiasis (n = 16), pneumocystosis
(n = 6), tuberculosis (n = 20), cryptococcosis (n = 44) and histo-
plasmosis (n = 10). As negative controls we used 30 respiratory
negative samples for P. brasiliensis or any of the most common
respiratory infectious pathogens diagnosed by culture and/or
speciﬁc stains as Gomori methenamine silver in the Pneu-
mocystis cases and 21 peripheral blood samples from healthy
individuals (Table 1). Additionally, the speciﬁcity of the nested-
PCR was also evaluated using puriﬁed DNA isolated from
cultures of different microorganisms (n = 35) previously iden-
tiﬁed by culture and/or sequencing (Table 2).
Processing  of  clinical  samplesRespiratory tract specimens (BAL, BL ﬂuid and sputum) and
body ﬂuids, including peritoneal ﬂuid, pleural ﬂuid and cere-
brospinal ﬂuids (CSF) were collected in 50 mL  sterile Falcon
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Table 1 – Samples used to evaluate speciﬁcity during the standardization of the nested PCR assay for the diagnosis of
Paracoccidioides brasiliensis.
Kind of patient Type of sample Diagnosis
Negative controls
(n:51)
Respiratory
symptomatic
(n:30)
BAL (25)
BL (4)
Sputum (1)
Healthy individuals (n:21) Whole blood (21)
Positive controls
(n:25)
Respiratory
symptomatic
(n:25)
BAL (2)
Paracoccidioides
brasiliensis (n:25)
Biopsies (15)
Sputum (8)
Clinical samples
(n:191)
Samples used to
evaluate the
speciﬁcity (n:115)
Respiratory
symptomatic
Body  ﬂuids (4)
Aspergillus fumigatus (n:1)
Candida albicans (n:1)
Candida tropicalis (n:2)
Tracheal aspirates
(9)
Aspergillus fumigatus (n:1)
Candida albicans (n:6)
Candida tropicalis (n:1)
Mycobacterium tuberculosis (n:1)
CSF (24) Cryptococcus neoformans (n:24)
Biopsies (22)
Aspergillus fumigatus (n:4)
Aspergillus ﬂavus (n:2)
Candida spp (n:1)
Candida albicans (n:3)
Candida parasilopsis (n:1)
Candida guillermondii (n:1)
Cryptococcus neoformans (4)
Histoplasma capsulatum (n:5)
Mycobacterium tuberculosis (n:1)
Sputum (9)
Aspergillus fumigatus (n:2)
Mycobacterium tuberculosis (n:7)
BL (16)
Aspergillus fumigatus (n:3)
Mycobacterium tuberculosis (n:7)
Cryptococcus neoformans (6)
BAL (31)
Aspergillus fumigatus (n:4)
Aspergillus ﬂavus (n:1)
Aspergillus versicolor (n:1)
Mycobacterium tuberculosis (n:4)
Cryptococcus neoformans (10)
Histoplasma capsulatum (n:5)
Pneumocystis jirovecii (n:6)
ﬂuid.BAL,  bronco alveolar lavage; BL, bronchial lavage; CSF,  cerebrospinal 
tubes (Becton Dickinson) and centrifuged at 1550 × g for 30 min
(Centra MP4R, IEC). The fresh tissues (biopsies) were manually
homogenized in 3 mL  of sterile saline solution. The pelleted
samples and the homogenate obtained were used for culture
and Gomori methenamine stain, and 0.6 mL  of each sample
was stored at −20 ◦C for subsequent DNA extraction. Processed
clinical samples were cultured on Sabouraud dextrose agar
and Mycosel (Becton Dickinson) by incubation at room tem-
perature (18–22 ◦C) for 20–30 days and were examined weekly
macroscopically and microscopically. These procedures were
carried out in a biosafety laboratory level 3 (BSL3).
DNA  extraction
Two hundred microliters of each previously processed clini-
cal sample or yeast suspension were used for DNA extraction
®and puriﬁcation. The QIAamp DNA Mini kit (Qiagen, Hilden-
berg, Germany) was used with some modiﬁcations: the initial
incubation with lysis buffer was performed at 65 ◦C for one
hour, followed by AL buffer incubation at 90 ◦C for 10 min  andadditional incubation with recombinant lyticase (1 UI/L) at
37 ◦C for 45 min. For ﬁlamentous fungal isolates, DNA extrac-
tion was performed using the phenol–chloroform method or
a commercial kit with Genomic G-100 columns (Qiagen Inc.,
CA).31 DNA extraction from whole blood was performed using
a protocol described by Einsele et al.,32 with some modiﬁ-
cations. The relative concentrations of DNA extracted were
determined using a NanoDrop ND2000 (Thermo Scientiﬁc).
P.  brasiliensis  nested  PCR  assay
Speciﬁc primers for P. brasiliensis that target the gene encod-
ing the gp43 membrane protein, were used in a nested PCR
reaction as described by Bialek et al.,23 with minor modiﬁca-
tions. The master mix  for the ﬁrst PCR consisted of 5 L of
puriﬁed DNA in a total PCR volume of 50 L with ﬁnal con-
centrations of 3 mM MgCl2 (Invitrogen), 0.2 M of each outer
and inner primer (Invitrogen) and 0.03 U of Taq polymerase
(Invitrogen). The mixture was incubated at 94 ◦C for 5 min; 35
cycles of 94 ◦C for 30 s, 50 ◦C for 30 s, and 72 ◦C for 1 min; and a
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Table 2 – Results of the Paracoccidioides brasiliensis nested PCR assay to several fungi and related microorganisms.
Molecular analysis
Isolates Strain source Nested PCR gp43
Aspergillus fumigatus CIB  −
Aspergillus terreus CDC  −
Aspergillus ﬂavus CIB −
Aspergillus niger CDC −
Cryptococcus neoformans CIB −
Cryptococcus gattii CIB −
Candida albicans CIB −
Candida guillermondii CIB −
Candida tropicalis CIB −
Candida parasilopsis CIB −
Candida dubliniensis CIB −
Candida glabrata CIB −
Candida krusei CIB −
Candida lusitanae CIB −
Candida bracariensis CIB −
Candida ohmeri CIB −
Candida famata CIB −
Candida ortopsilosis CIB  −
Candida metapsilosis CIB  −
Paracoccidioides brasiliensis ATCC 60855 +
Paracoccidioides brasiliensis CIB/Pb339 +
Paracoccidioides brasiliensis CIB/Pb18 +
Paracoccidioides lutzii CIB −
Coccidioides immitis ATCC 28868 −
Blastomyces dermatitidis CDC 2008011573 −
Blastomyces dermatitidis ATCC 26199 −
Histoplasma capsulatum var. capsulatum CDC/Thon −
Histoplasma capsulatum var. capsulatum G217B −
Histoplasma capsulatum var. capsulatum G184B −
Histoplasma capsulatum var. capsulatum CDC/3670 −
Histoplasma capsulatum var. duboisii CDC/5822 −
Histoplasma capsulatum var. duboisii CDC/5823 −
Schizophyllum commune CIB −
Mycobacterium tuberculosis CIB −
Mycobacterium avium CIB −
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oCIB, Corporación para Investigaciones Biológicas, Medellín, Colombi
negative result; +, PCR positive result.
nal extension at 72 ◦C for 5 min. For the second (nested) PCR,
he mix  was similar to the ﬁrst, except that 2 L of the ﬁrst PCR
roduct was used as template DNA and the reaction mixture
as incubated at 94 ◦C for 5 min; 30 cycles of 94 ◦C for 30 s and
2 ◦C for 1 min; with ﬁnal extension at 72 ◦C for 5 min. The ﬁnal
roduct of the nested PCR is a 196 bp fragment that indicates
he presence of P. brasiliensis DNA in the samples analyzed. As
 positive control, 10 L containing 10 ng of puriﬁed P. brasilien-
is DNA was used in all PCR assays. In order to ensure validity
nd reliability of our results, positive and negative internal
ontrols were always included. Additionally, sample prepa-
ation, DNA extraction, mix  and primer preparation as well
s the agarose gel electrophoresis were performed in sepa-
ated laboratory areas using different sets of pipettes for each
tep and in separate air-ﬂow hoods regularly decontaminated
sing UV light and DNAZap solution.
As a control to verify ampliﬁable DNA or to detect the pres-
nce of PCR inhibitors in the clinical samples, a PCR designed
o amplify the human gene for -globin was carried out as
escribed by Bialek et al.33 All of the PCR reactions were run
n a Peltier Thermal Cycler PT100 (MJ  Research, USA). The PCRC, Centers for Disease Control and Prevention, Atlanta, USA; −, PCR
products were visualized by electrophoresis on 2% agarose
gels (Sigma Chemical Co., St. Louis, MO, USA), using red gel
and a UV trans illuminator (Molecular imager® Gel DocT-
MXR+BIORAD). All of the nested PCR products were sequenced
to verify that the ampliﬁed DNA fragment corresponded to the
gp43 membrane protein of P. brasiliensis.
Detection  limit
To establish the detection limit of the nested PCR assay, we
extracted and quantiﬁed DNA from a P. brasiliensis yeasts sus-
pension and performed serial dilutions (1:10) ranging from
100 ng to 1 fg units. Each of these dilutions was used for a
speciﬁc PCR, to determine the amount of DNA at the assay’s
detection limit.
Data  analysisThe sequences obtained were properly edited and aligned
using Sequencher software (version 4.8) and homology
searches of all sequences were carried out using the BLASTn
i s . 2 0 1 5;1  9(4):376–383
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Fig. 1 – Detection limit of the Paracoccidioides brasiliensis
nested PCR. M:  molecular weight marker, 1: 40 ng/L, 2:
400 pg/L, 3: 4 pg/L, 4: 40 fg/L, 5: 1 fg/L, 6: empty.380  b r a z j i n f e c t d 
program from the National Center for Biotechnology Infor-
mation, Washington, DC. The sequences were categorized
according to E-values (error probability) as provided by
BLASTn, using values lower than 1 × 10−40.
Sensitivity and speciﬁcity rates of the P. brasiliensis nested
PCR were calculated using those samples diagnosed positively
by microbiological culture or microscopic observation of the
fungus on direct exam or histopathology and according to the
method of Galen and Gambino.34
Results
Detection  of  P.  brasiliensis  gp  43  DNA  in  clinical  samples
A total of 25 clinical samples from patients with paracoccid-
ioidomycosis that had been diagnosed by culture or Gomori
methenamine stain were analyzed through nested PCR. Fif-
teen samples (60%) turned out positive by culture and 10 were
positive by KOH direct examination (40%) and all of the 25
specimens tested positive for gp43 nested PCR assay. To assess
the speciﬁcity of this nested PCR assay, 115 clinical samples
collected from patients with other diagnosed infections by
culture and/or speciﬁc stains (Gomori methenamine silver)
and 51 negative controls (30 respiratory negative samples and
21 peripheral blood samples from healthy individuals) were
analyzed. Our P. brasiliensis gp43 nested PCR exhibited 100%
speciﬁcity using both negative controls as well as those clinical
samples diagnosed with other infections (Table 3).
The presence of PCR inhibitors was ruled out because all
of the clinical samples with negative result in the P. brasilien-
sis gp43 nested PCR assay allowed ampliﬁcation of a speciﬁc
fragment of the human -globin gene.
The entire puriﬁed DNA from the three P. brasiliensis iso-
lates used (ATCC 60855, Pb339 and Pb18), tested positive in
the nested PCR assay; however, the DNA isolated from culture
of P. lutzii (Pb 01 Like) yielded a negative result in the nested
PCR assay. In addition, none of the DNA isolated from cultures
of related microorganisms tested positive in the P. brasiliensis
gp43 nested PCR assay (Table 2).
Cross-contamination during the extraction procedure was
not evident. All of the DNA extraction controls tested negative
in the nested PCR assays.
Detection  limits
The optimized nested PCR conditions in our laboratory
allowed detection down to a 1 fg of P. brasiliensis DNA (Fig. 1).
Controls
All of the DNA extraction controls tested negative in the nested
PCR assays; therefore any possible cross-contamination dur-
ing the extraction procedure was ruled out.
DiscussionUsually the diagnosis of PCM is based mainly on direct
observation of multi budding yeast cells in clinical samples;
microbiological growth in culture is too slow and a speciﬁcdiagnosis can be obtained only on late stages of fungal growth.
Additionally, the culture must be kept for at least two months
before reporting a negative result. Although PCM immuno-
diagnostic is also widely employed, these tests may lead
to cross-reactivity with other fungi or yield false-negative
results.14,20,26,27 Due to the above reasons, molecular tech-
niques such as PCR have been, although it is still at early
stages of being incorporated as routine diagnostic test for
PCM.20,23,24,27
Regarding the design of speciﬁc primers for fungal molec-
ular diagnosis, it is clear that within the gene chosen as
target must exist very conserved regions that could serve as
primer binding sites. Additionally, such regions must ﬂank
sequences with sufﬁcient variability to permit discrimination
at genus level, at least. Therefore ribosomal genes particu-
larly those related with 18S RNA are constantly used as they
exist in all organisms in high amounts, which favors high
sensitivity.20,35,36 Furthermore the rRNA gene contains both
conserved (28S, 5.8S and 18S) and speciﬁc (ITS1 and ITS2)
regions, making this gene a valuable option for molecular
identiﬁcation in the majority of microorganisms.
However, for the molecular diagnosis of PCM, several assays
with the 18S rRNA genes of P. brasiliensis have evidenced high
homology between this fungus and other similar fungi like
Histoplasma capsulatum or Blastomyces dermatitidis.20 As a result
other associated speciﬁc genes have been used, such as the
P. brasiliensis gp43 gene, which enhances the speciﬁcity of
PCM diagnosis.23 Gp43 is a 43-kDa glycoprotein that partici-
pates in the microbial interaction with the host cells, its initial
interaction helping fungal internalization, incoming success-
ful infection and posterior dissemination.37,38
After complete cloning, sequencing and characterization of
the gene encoding the gp43 region, numerous primer sets have
been designed for molecular diagnosis of P. brasiliensis.23,28,39,40
In this study we  ampliﬁed a speciﬁc fragment of the
sequence of gp43 P. brasiliensis protein deposited in the Gen-
Bank (U26160) using previously described primers in 2000 by
Bialek et al.23; additionally, and in order to increase the disrup-
tion efﬁciency and liberate the P. brasiliensis DNA from tissue
homogenates, the DNA extraction protocol used an additional
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Table 3 – Nested PCR results obtained on human clinical samples from patients with paracoccidioidomycosis (A) or other
respiratory diseases different from paracoccidioidomycosis as well as healthy individuals taken as controls (B).
Specimen type Proven disease Number of samples
Total Positive PCR
(A)
Bronco alveolar lavage Paracoccidioidomycosis 2 2
Sputum Paracoccidioidomycosis 8 8
Biopsy Paracoccidioidomycosis 15 15
Total 25 25
(B)
Bronco alveolar
lavage
Cryptococcosis 10 0
Pneumocystis pneumonia 6 0
Histoplasmosis 5 0
Aspergillosis 6 0
Tuberculosis 4 0
No disease 25 0
Bronchial lavage
Cryptococcosis 6 0
Aspergillosis 3 0
Tuberculosis 7 0
No disease 4 0
Sputum
Aspergillosis 2 0
Tuberculosis 7 0
No disease 1 0
Tracheal aspirate
Aspergillosis 1 0
Candidiasis 7 0
Tuberculosis 1 0
Biopsy
Candidiasis 6 0
Aspergillosis 6 0
Cryptococcosis 4 0
Tuberculosis 1 0
Histoplasmosis 5 0
Cerebrospinal ﬂuid Cryptococcosis 24 0
Pleural ﬂuid Aspergillosis 1 0
Peritoneal ﬂuid Candidiasis 3 0
i
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sWhole blood No disease 
Total 
ncubation period with recombinant lyticase (1 UI/L) at 37 ◦C
or 45 min.
Given that the DNA isolated from cultures of P. lutzii yielded
egative results with our P. brasiliensis nested PCR assay, we
ecided to conﬁrm these results aligning different sequences
f gp43 protein of P. lutzii, obtained from the web-page of the
ungal Genomics Group at the Broad Institute, to run an in-
ilico PCR using the sequences of our primers. Effectively we
ound that the primers used in our nested PCR did not match
. lutzii sequences.
Polymorphisms in the sequence of the gene encoding for
he glycoprotein gp43 in P. lutzii in contrast to P. brasiliensis have
een reported; these polymorphisms cause signiﬁcant and
ecisive changes on some motifs of the protein, interfering
irectly with its structure and function. The most signiﬁ-
ant differences between both gp43 sequences of P. lutzii and
. brasiliensis are: the homology rate in the gp43 sequence
etween those Paracoccidioides species is only 81%; the gp43
rotein in P. lutzii is not glycosylated due to a change in the
mino acid sequence from NRT to KRT in the N-glycosylation
ite. P. lutzii gp43 protein has an amino acid change from NKP21 0
166 0
to NEP in the glucanase active site. However, this protein retain
full glucanase activity,36 in contrast to that seen in other stud-
ies with P. brasiliensis gp43 protein37; in respect to the role
of gp43 protein in the adhesion of yeast to components of
the extracellular matrix, the gp43 protein in both Paracoccid-
ioides species maintain similar ability to bind to laminin and
ﬁbronectin proteins. Finally, it is suggested that the gp43 pro-
tein is expressed at low amounts by P. lutzii both in vivo and in
vitro.36 Although both Paracoccidioides species express gp43 gly-
coprotein, there are some genetic differences in P. lutzii which
modify structural properties that possibly affect functional-
ity and protein expression, therefore, its recognition by the
primers used in our nested PCR.41,42
We  found that the P. brasiliensis nested PCR assay tested
positive for all 25 clinical samples from patients diagnosed
with PCM. None of the 115 clinical samples from patients diag-
nosed with infections other than PCM tested positive for P.
brasiliensis in the nested PCR assay, translating 100% speci-
ﬁcity.
In conclusion and in line with the report by Bialek et al.,23
P. brasiliensis nested PCR assay is a sensitive, speciﬁc, and
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reproducible diagnostic method to be used in different clin-
ical samples. We  conﬁrmed a high sensitivity for detecting P.
brasiliensis DNA in concentrations down to 1 fg. The nested PCR
may be a useful tool not only for the rapid diagnosis of acute or
chronic PCM but also for monitoring parasite clearance during
therapy and follow-up. Although currently in Colombia there
has been no reported case of PCM by P. lutzii, as perspective of
this study, we  suggest the necessity of future studies focusing
in the design of primers able to detect molecular targets more
conserved in both species in order to detect both P. brasiliensis
and P. lutzii and be able to make a timely diagnosis of PCM at
any endemic area for this mycosis.
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